Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel therapeutic strategies for metabolic disorders described in recent patents

Sep. 8, 2006

Novel compounds claimed for treatment of inflammatory disorders in recent patents

Sep. 7, 2006

Novel nebivolol metabolites for cardiovascular disorders disclosed in recent Mylan patents

Sep. 7, 2006

Recent patents describe new compounds for diabetes and related disorders

Sep. 7, 2006

Novel PI3Kdelta inhibitors reported in recent Ono patent

Sep. 6, 2006

Ajinomoto patents novel coagulation factor Xa inhibitors

Sep. 6, 2006

New agents for treating neurological disorders disclosed in recent patent literature

Sep. 6, 2006

Recent Meiji Dairies and NeuroMed patents disclose novel analgesic agents

Sep. 6, 2006

Samaritan and Georgetown University jointly disclose novel agents for HIV infection

Sep. 5, 2006

New agents for urinary incontinence disclosed in recent Norgine patent

Sep. 5, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.